Diagnostic imaging company RadNet (NASDAQ:RDNT) reported Q4 CY2024 results , with sales up 13.5% year on year to $477.1 ...

Private Advisor Group LLC purchased a new stake in RadNet, Inc. (NASDAQ:RDNT – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission.

Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good day, and welcome to the RadNet, Inc. Fourth Quarter 2024 ...

Bank of New York Mellon Corp lowered its holdings in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 3.1% during the ...

The additional sites RadNet is onboarding will help us enable more convenient access to grow scan volume in response to physician demand. It also underscores our strong relationship with this ...

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

RadNet Inc (NASDAQ:RDNT) is set to release its Q4 2024 earnings on Feb 28, 2025. The consensus estimate for Q4 2024 revenue ...

Total Company Revenue increased 13.5% to a quarterly record of $477.1 million in the fourth quarter of 2024 from $420.4 million in the fourth ...

Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare industry to assess business performance, and is a measure of leverage capacity ...

Good day, and welcome to the RadNet, Inc. Fourth Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation ...

The expansion plans build on previously established Nociscan sites with RadNet affiliates in both states and are driven by the increased availability of MR Spectroscopy (MRS) and enhanced remote ...